为改善纳米SiO2粒子在聚L-乳酸基体中的分散性,将乳酸齐聚物接枝到纳米SiO2粒子表面,通过IR,29Si MAS NMR和TGA对改性SiO2进行表征.以聚L-乳酸(PLLA)为基体,加入乳酸齐聚物接枝改性的二氧化硅(g-SiO2)粒子,采用溶液浇铸法制备PLLA/g-SiO...为改善纳米SiO2粒子在聚L-乳酸基体中的分散性,将乳酸齐聚物接枝到纳米SiO2粒子表面,通过IR,29Si MAS NMR和TGA对改性SiO2进行表征.以聚L-乳酸(PLLA)为基体,加入乳酸齐聚物接枝改性的二氧化硅(g-SiO2)粒子,采用溶液浇铸法制备PLLA/g-SiO2纳米复合材料,测试其在模拟体液(SBF)中的生物活性.通过XRD,IR,SEM和EDS表征手段,考察材料表面类骨磷灰石形成能力.结果表明,乳酸齐聚物成功地接枝到SiO2表面,当反应36 h时,g-SiO2接枝率最大(9.22%).随着g-SiO2含量增加和浸泡时间的延长,材料表面最初形成的无定形沉积物矿化成碳酸羟基磷灰石(Carbonated hydroxyapatite,CHA),钙磷比为1.72,类似于人骨无机质,表明g-SiO2的引入能明显加速复合材料表面CHA沉积,该复合材料有望成为骨修复填充材料和组织工程支架材料.展开更多
Microspheres containing an antimetabolite drug 5-Fluorouracil were prepared from (poly(lactic) acide)(PLA) or poly(lactic acid)-polyethylene glycol(PLA-PEG) as the carrier by using a water-in-oil-in-water emulsion sol...Microspheres containing an antimetabolite drug 5-Fluorouracil were prepared from (poly(lactic) acide)(PLA) or poly(lactic acid)-polyethylene glycol(PLA-PEG) as the carrier by using a water-in-oil-in-water emulsion solvent evaporation technique. The conditions of the microspheres preparation such as polymer concentration in organic solvent, relative molecular weight of PLA-PEG and PLA/PEG mass ratio were discussed. The surface morphology and the size of the microspheres were observed by SEM. The drug content of microspheres was examined by TGA and the drug release in vitro was evaluated. According to the results, the drug content increased with the nano-silica used. The highest drug content in this study was 39.9%. The drug-release kinetics satisfied the requirements of controlled drug-release.展开更多
文摘为改善纳米SiO2粒子在聚L-乳酸基体中的分散性,将乳酸齐聚物接枝到纳米SiO2粒子表面,通过IR,29Si MAS NMR和TGA对改性SiO2进行表征.以聚L-乳酸(PLLA)为基体,加入乳酸齐聚物接枝改性的二氧化硅(g-SiO2)粒子,采用溶液浇铸法制备PLLA/g-SiO2纳米复合材料,测试其在模拟体液(SBF)中的生物活性.通过XRD,IR,SEM和EDS表征手段,考察材料表面类骨磷灰石形成能力.结果表明,乳酸齐聚物成功地接枝到SiO2表面,当反应36 h时,g-SiO2接枝率最大(9.22%).随着g-SiO2含量增加和浸泡时间的延长,材料表面最初形成的无定形沉积物矿化成碳酸羟基磷灰石(Carbonated hydroxyapatite,CHA),钙磷比为1.72,类似于人骨无机质,表明g-SiO2的引入能明显加速复合材料表面CHA沉积,该复合材料有望成为骨修复填充材料和组织工程支架材料.
文摘Microspheres containing an antimetabolite drug 5-Fluorouracil were prepared from (poly(lactic) acide)(PLA) or poly(lactic acid)-polyethylene glycol(PLA-PEG) as the carrier by using a water-in-oil-in-water emulsion solvent evaporation technique. The conditions of the microspheres preparation such as polymer concentration in organic solvent, relative molecular weight of PLA-PEG and PLA/PEG mass ratio were discussed. The surface morphology and the size of the microspheres were observed by SEM. The drug content of microspheres was examined by TGA and the drug release in vitro was evaluated. According to the results, the drug content increased with the nano-silica used. The highest drug content in this study was 39.9%. The drug-release kinetics satisfied the requirements of controlled drug-release.
